The company presented its results this week at a conference and anticipates that with additional validation early next year, it will be ready to file for regulatory approval.

IF PAULA MENDES achieves her goals, her nanotechnology innovations will soon allow doctors to diagnose cancer with greater ...

A large study to gauge how susceptible US dairy and beef cattle are to influenza A viruses found that they are susceptible to ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

The global in vitro diagnostics market (IVD) was valued at $67,111 million in 2019, and is projected to reach $91,093 million at a CAGR of 4.8% from 2020 to 2027. For instance, in clinical chemistry ...

The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...

According to a new market research report titled, 'Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type (Troponin, CK-MB ...

According to a new market research report titled, 'Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type ...

The global mycotoxin testing market is poised for substantial growth, with its valuation expected to rise from 𝐔𝐒𝐃 ...

VolitionRx (VNRX) announced the expansion of its Nu.Q Vet Cancer Test supply agreement with Fujifilm Vet Systems in Japan, to include ...

We did not classify studies that were missing either (1) Pearson correlation coefficients or Bland–Altman analyses with matching venous blood values or (2) measures of assay precision (CVs) or ...

There are several types of these tests. An immunoassay (IA) test is most common because it is the quickest and most cost-effective. However, IA tests can give false-positive results. In this case ...